PPHM has one of the most interesting drug candidates I've ever seen. But the management team has a habit of relying on PIPE financing a little too much. It's really killed the stock price over the last couple of years. But now that they have an IB, I think they are going to start promoting a lot more. In the short term, I’m hoping that this is a good de-listing avoidance play. In time, who knows... Could be promising.